Mild changes over time are a normal part of the process
These cells remain metabolically active and secrete a series of proteins and bioactive factors
Potential benefits for the gut include: Reducing intestinal inflammation in IBD and colitis Modulating immune response to prevent overactivation Decreasing harmful bacterial overgrowth and supporting a healthier gut microbiome Enhancing epithelial barrier function to prevent leaky gut How it works: KPV helps regulate cytokine production, balancing the immune systems activity so it calms inflammation without shutting down natural defenses
Both pills launched at $149 per month for self-pay patients, a fraction of the cost of injectable GLP-1s, which have typically run upwards of $1,000 per month
Other GLP-1 receptor agonists such as liraglutide 3mg (Saxenda) or tirzepatide (Mounjaro, per NICE TA1026) may be considered according to local commissioning arrangements and NICE guidance
With the FDAs approval of the first-ever oral GLP1 for weight loss, Novo Nordisk has secured a strategic advantage in one of the fastestgrowing therapeutic categories